Lazard US Equity Concentrated Portfolio
LEVIX
NASDAQ- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Lazard US Equity Concentrated Portfolio (LEVIX) is an open-end mutual fund managed by Lazard Asset Management LLC that seeks long-term capital appreciation through concentrated investments primarily in U.S. equities. The fund invests in a portfolio of 20 to 40 high-conviction stocks selected from large-, mid-, and small-cap companies across various sectors, including technology, consumer discretionary, healthcare, financials, and industrials; it employs a fundamental, bottom-up research process emphasizing companies with sustainable competitive advantages, strong management, and attractive valuations. LEVIX targets institutional and high-net-worth individual investors seeking active U.S. equity exposure with lower turnover and higher active share compared to broad market benchmarks like the S&P 500 Index. Lazard Asset Management LLC, founded in 1848 and headquartered in New York, operates globally with offices in over 20 countries across North America, Europe, Asia, and the Middle East; as a subsidiary of Lazard Inc. (NYSE: LAZ), it manages approximately $250 billion in assets across equity, fixed income, alternatives, and multi-asset strategies. The firm serves a diverse client base including public and corporate pension plans, sovereign wealth funds, endowments, foundations, insurance companies, and private clients. LEVIX, launched in 2006, represents part of Lazard's suite of U.S. equity strategies, which also includes institutional separate accounts and other mutual funds like the Lazard US Equity Institutional Portfolio. In recent developments, Lazard Asset Management announced strategic enhancements to its equity platform in 2024, including the integration of advanced ESG analytics into core strategies like LEVIX to better address client demands for sustainable investing without compromising returns. The firm completed a key acquisition of a boutique U.S. small-cap equity manager in early 2025, bolstering its concentrated portfolio capabilities and expanding the research team supporting LEVIX. Additionally, Lazard reported robust inflows into its U.S. equity funds amid market volatility, with LEVIX delivering strong relative performance driven by overweight positions in select technology and healthcare holdings during the 2024-2025 period.